Trial intelligence / Profile preview

Metamizole for chronic cancer pain

NCT02181920Phase 4Terminated

Sponsor
Boehringer Ingelheim
Start
Mar 2000
Primary completion
Nov 2000
Modality
Small Molecules
01

Overview

A Phase 4 trial of metamizole in cancer pain, sponsored by Boehringer Ingelheim. Started Mar 2000; status: terminated.

02

Drugs

metamizole
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT02181920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02181920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call